Secret Service investigating Detroit patient data breach

Laura Pedulli | | Health Exec | Cybersecurity

The U.S. Secret Service is investigating a breach of personal patient information at two Detroit-area hospital systems, according to Detroit Free Press.

The news followed an earlier announcement that an employee of Detroit Medical Center was found in possession of protected health information, including the names, personal health information, dates of birth and Social Security numbers of 1,087 patients at Harper University Hospital in Detroit. The DMC removed the employee’s access to all computer systems after police informed it of the breach and affected patients received free credit reporting services, according to the article.

In regard to the Secret Service investigation, few details have been released and no arrests or charges have yet been filed. In addition to protecting the president, the Secret Service has jurisdiction over many financial crimes and for investigating identity crimes and money counterfeiting operations, according to Detroit Free Press. 

Laura Pedulli

Related Content

FBI seeking extradition of Israeli prisoner accused of $500M in ransomware attacks
Data breach at chain of clinics impacts 450K patients
Nebraska becomes first state to sue Change Healthcare over data breach
Christmas ransomware exposed over 300K patient records to dark web
Cryo-frozen tissue manufacturer suffers cyberattack
First surgical device of its kind granted key FDA exemption

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Radiology Business
Policies and regulations shaping radiology in 2025

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.